FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

45327011000036107: agalsidase alfa 3.5 mg / 3.5 mL injection, 3.5 mL vial (medicinal product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
291891011000036111 agalsidase alfa 3.5 mg / 3.5 mL injection, 3.5 mL vial (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
291893011000036112 agalsidase alfa 3.5 mg/3.5 mL injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
agalsidase alfa 3.5 mg/3.5 mL injection, vial Is a medicinal product unit of use true Inferred relationship Some
agalsidase alfa 3.5 mg/3.5 mL injection, vial Is a agalsidase alfa true Inferred relationship Some
agalsidase alfa 3.5 mg/3.5 mL injection, vial has intended active ingredient agalsidase alfa true Inferred relationship Some 293702428
agalsidase alfa 3.5 mg/3.5 mL injection, vial has Australian BoSS agalsidase alfa true Inferred relationship Some 293702428
agalsidase alfa 3.5 mg/3.5 mL injection, vial has manufactured dose form injection true Inferred relationship Some
agalsidase alfa 3.5 mg/3.5 mL injection, vial has unit of use vial true Inferred relationship Some 293702429
Inbound Relationships Type Active Source Characteristic Refinability Group
Replagal 3.5 mg/3.5 mL injection, 3.5 mL vial Is a True agalsidase alfa 3.5 mg/3.5 mL injection, vial Inferred relationship Some
agalsidase alfa 3.5 mg/3.5 mL injection, 3.5 mL vial has MPUU True agalsidase alfa 3.5 mg/3.5 mL injection, vial Inferred relationship Some 1

Reference Sets

List of Medicines for Brand Consideration reference set

Medicinal product unit of use reference set

Back to Start